Simplex Trading, LLC Ventyx Biosciences, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$2.31 - $5.59 $1,298 - $3,141
-562 Reduced 4.31%
12,482 $28,000
Q1 2024

Apr 25, 2024
BUY
$1.9 - $10.13 $1,787 - $9,532
941 Added 7.77%
13,044 $71,000
Q4 2023

Feb 02, 2024
BUY
$2.08 - $31.18 $25,174 - $377,371
12,103 New
12,103 $29,000

Others Institutions Holding VTYX

# of Institutions
125
Shares Held
52.9M
Call Options Held
35.3K
Put Options Held
83K
View Full List

About Ventyx Biosciences, Inc.

VTYX Quotes by TradingView
  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $128M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email